WallStSmart

Bio Green Med Solution, Inc. (BGMS)vsJohnson Controls International PLC (JCI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Johnson Controls International PLC generates 1342995% more annual revenue ($25.00B vs $1.86M). JCI leads profitability with a 14.3% profit margin vs -118.3%. JCI earns a higher WallStSmart Score of 57/100 (C).

BGMS

Hold

46

out of 100

Grade: D+

Growth: 6.3Profit: 2.0Value: 5.0Quality: 5.8
Piotroski: 4/9Altman Z: -77.25

JCI

Buy

57

out of 100

Grade: C

Growth: 6.0Profit: 7.5Value: 4.3Quality: 4.5
Piotroski: 5/9Altman Z: 1.11

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BGMS2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
710.0%10/10

Revenue surging 710.0% year-over-year

JCI3 strengths · Avg: 8.7/10
Market CapQuality
$88.44B9/10

Large-cap with strong market position

Return on EquityProfitability
26.6%9/10

Every $100 of equity generates 27 in profit

Free Cash FlowQuality
$1.50B8/10

Generating 1.5B in free cash flow

Areas to Watch

BGMS4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$5.78M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-46.1%2/10

ROE of -46.1% — below average capital efficiency

Free Cash FlowQuality
$-352,0002/10

Negative free cash flow — burning cash

JCI3 concerns · Avg: 2.7/10
PEG RatioValuation
1.634/10

Expensive relative to growth rate

P/E RatioValuation
40.1x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.112/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BGMS

The strongest argument for BGMS centers on Price/Book, Revenue Growth. Revenue growth of 710.0% demonstrates continued momentum.

Bull Case : JCI

The strongest argument for JCI centers on Market Cap, Return on Equity, Free Cash Flow.

Bear Case : BGMS

The primary concerns for BGMS are EPS Growth, Market Cap, Return on Equity.

Bear Case : JCI

The primary concerns for JCI are PEG Ratio, P/E Ratio, Altman Z-Score. A P/E of 40.1x leaves little room for execution misses.

Key Dynamics to Monitor

BGMS profiles as a hypergrowth stock while JCI is a value play — different risk/reward profiles.

JCI carries more volatility with a beta of 1.30 — expect wider price swings.

BGMS is growing revenue faster at 710.0% — sustainability is the question.

JCI generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

JCI scores higher overall (57/100 vs 46/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bio Green Med Solution, Inc.

INDUSTRIALS · BUILDING PRODUCTS & EQUIPMENT · USA

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. The company is headquartered in Kuala Lumpur, Malaysia.

Johnson Controls International PLC

INDUSTRIALS · BUILDING PRODUCTS & EQUIPMENT · USA

Johnson Controls International plc is an Irish-domiciled multinational conglomerate headquartered in Cork, Ireland, that produces fire, HVAC, and security equipment for buildings.

Want to dig deeper into these stocks?